Chong Kun Dang Pharmaceutical Corp.

KOSE:A185750 주식 보고서

시가총액: ₩1.4t

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Chong Kun Dang Pharmaceutical 미래 성장

Future 기준 확인 0/6

Chong Kun Dang Pharmaceutical 의 수익은 연간 21.8% 감소할 것으로 예상되는 반면, 연간 수익은 1.9% 로 증가할 것으로 예상됩니다. 1.9% 연간. EPS는 연간 23.1% 만큼 쇠퇴할 것으로 예상됩니다. 자기자본이익률은 3년 후 11.4% 로 예상됩니다.

주요 정보

-18.6%

수익 성장률

-21.1%

EPS 성장률

Pharmaceuticals 수익 성장36.9%
매출 성장률2.1%
향후 자기자본 수익률11.6%
애널리스트 커버리지

Good

마지막 업데이트22 Aug 2024

최근 미래 성장 업데이트

Recent updates

Investors Aren't Buying Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Earnings

Sep 27
Investors Aren't Buying Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Earnings

Does Chong Kun Dang Pharmaceutical (KRX:185750) Deserve A Spot On Your Watchlist?

Sep 08
Does Chong Kun Dang Pharmaceutical (KRX:185750) Deserve A Spot On Your Watchlist?

Are Investors Undervaluing Chong Kun Dang Pharmaceutical Corp. (KRX:185750) By 41%?

Jul 30
Are Investors Undervaluing Chong Kun Dang Pharmaceutical Corp. (KRX:185750) By 41%?

Investors Don't See Light At End Of Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Tunnel

Jun 12
Investors Don't See Light At End Of Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Tunnel

Chong Kun Dang Pharmaceutical (KRX:185750) Seems To Use Debt Rather Sparingly

May 27
Chong Kun Dang Pharmaceutical (KRX:185750) Seems To Use Debt Rather Sparingly

A Look At The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Apr 09
A Look At The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?

Apr 19
Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?

Here's Why I Think Chong Kun Dang Pharmaceutical (KRX:185750) Is An Interesting Stock

Apr 05
Here's Why I Think Chong Kun Dang Pharmaceutical (KRX:185750) Is An Interesting Stock

Declining Stock and Solid Fundamentals: Is The Market Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750)?

Mar 09
Declining Stock and Solid Fundamentals: Is The Market Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750)?

Estimating The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Feb 24
Estimating The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

The Chong Kun Dang Pharmaceutical (KRX:185750) Share Price Is Up 112% And Shareholders Are Boasting About It

Feb 11
The Chong Kun Dang Pharmaceutical (KRX:185750) Share Price Is Up 112% And Shareholders Are Boasting About It

Is Chong Kun Dang Pharmaceutical Corp. (KRX:185750) An Attractive Dividend Stock?

Jan 27
Is Chong Kun Dang Pharmaceutical Corp. (KRX:185750) An Attractive Dividend Stock?

Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?

Jan 12
Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?

With EPS Growth And More, Chong Kun Dang Pharmaceutical (KRX:185750) Is Interesting

Dec 28
With EPS Growth And More, Chong Kun Dang Pharmaceutical (KRX:185750) Is Interesting

What Kind Of Shareholders Hold The Majority In Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Shares?

Dec 09
What Kind Of Shareholders Hold The Majority In Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Shares?

Could The Market Be Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750) Given Its Attractive Financial Prospects?

Nov 24
Could The Market Be Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750) Given Its Attractive Financial Prospects?

수익 및 매출 성장 예측

KOSE:A185750 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (KRW Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/20261,730,750121,829158,833169,2638
12/31/20251,643,038106,243139,833154,9008
12/31/20241,564,30095,571103,000137,5005
6/30/20241,666,522212,788196,160257,825N/A
3/31/20241,665,726202,243249,344321,128N/A
12/31/20231,669,404212,521249,354318,160N/A
9/30/20231,561,851136,097134,793206,913N/A
6/30/20231,542,134119,04552,863125,597N/A
3/31/20231,512,15499,38151,004103,844N/A
12/31/20221,488,34580,95314,67067,734N/A
9/30/20221,453,15970,692-31,83512,119N/A
6/30/20221,411,50844,292-24,84419,113N/A
3/31/20221,373,01845,096-35,29513,964N/A
12/31/20211,343,55942,720-38,93012,904N/A
9/30/20211,318,91452,31915,26866,304N/A
6/30/20211,335,06685,11638,97887,610N/A
3/31/20211,321,55888,79249,40892,670N/A
12/31/20201,303,00691,63367,506104,324N/A
9/30/20201,263,96596,31661,95595,132N/A
6/30/20201,186,15675,88960,98992,526N/A
3/31/20201,138,68960,91648,31076,123N/A
12/31/20191,079,33853,88252,42977,291N/A
9/30/20191,046,38751,32766,18089,129N/A
6/30/20191,000,91050,37855,22275,429N/A
3/31/2019971,68850,42227,15850,953N/A
12/31/2018956,21942,39917,98842,628N/A
9/30/2018934,98243,6824,84733,677N/A
6/30/2018919,53446,68821,12748,954N/A
3/31/2018893,20445,204N/A65,370N/A
12/31/2017884,36353,807N/A81,673N/A
12/31/2016831,98640,946N/A57,786N/A

애널리스트 미래 성장 예측

수입 대 저축률: A185750 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -21.8% ).

수익 vs 시장: A185750 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -21.8% ).

고성장 수익: A185750 의 수익은 향후 3년간 감소할 것으로 예상됩니다.

수익 대 시장: A185750 의 수익(연간 1.9% ) KR 시장( 10.5% 보다 느리게 성장할 것으로 예상됩니다. 10.5% 연간).

고성장 수익: A185750 의 수익(연간 1.9% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: A185750 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 11.4 %).


성장 기업 발견